ARCHIVES

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

This article is from The Cancer Letter archive.

Vol. 25 No. 13 | April 2, 1999

Download PDF Visit The Full Archive

Related Articles

In Brief: Bishop, Scein, Vaitkevicuis Named To NCAB; Hopkins Breaks Ground for Larger Center

October 7, 1994

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

February 11, 1994

Abstracts Of Papers Presented By Breast Cancer Task Force

July 16, 1976

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012

Scientific Misconduct: HHS To Change Role Of ORI In Response To Council Report

December 3, 1999

Marijuana-Derived Drug Less Effective Than Standard

March 29, 2002